DNAiTECH

Portable nucleic acid amplification technology for point-of-care diagnostics

Mauri ora te whenua, mauri ora te tāngata.

S-TECH

S-TECH is our front-end sample processing technology. This system enables the isolation of nucleic acids from any type of sample. S-TECH has been used for a large range of sample extractions, including nasal swabs, throat swabs, urine, faeces, soil, and plant tissue. Using S-TECH highly purified DNA can be prepared that is inhibitor-free for isothermal molecular amplification.

S-TECH can also be used for the isolation of extracellular vesicles, exosomes and microsomes using our low binding, precision track etched polycarbonate membranes

Second Generation DNAiTECH Instrument

Our first and second generation instruments were tube-based systems, the Gen 2 system was battery powered and field deployable. These tube systems combined Android smartphone technology with a simple Bluetooth connected handheld-instrument that used isothermal DNA amplification chemistry.

The Gen 2 systems are replaced by our innovative Gen 3 chip technology.

The DNAiTECH being focused on samples for a loop-mediated isothermal amplification of E. coli.

Third Generation DNAiTECH Instrument

Our generation 3.1 diagnostic chip system was trialed in Senegal in September 2025 with the Institut Pasteur de Dakar. In 2026 we are launching the generation 3.2 diagnostic system incorporating 8 independent reaction zones and fully integrated LAMP-CRISPR biochemistry in single pot diagnostic chip systems. Real-time quantitative detection capability is due to be launched in the generation 3.3 device in 2028.

News

TECHNOLOGY INNOVATION NETWORK

Yesterday, we attended the TIN awards night in Auckland at the Cloud and are grateful to have received one of the early stage company awards. Thank you, TIN, for this recognition. It is inspiring to see all the winners across various categories and to witness the vibrancy of the tech sector in New Zealand. These moments are to be savored on the start-up journey, and seeing so many mature companies born in New Zealand emerge as global players is truly motivating.

ANTIBIOTIC RESISTANCE: A GLOBAL THREAT TO HUMAN HEALTH

There is an alarming worldwide increase in antibiotic resistance. According to a new WHO report, between 2018 and 2023, antibiotic resistance rose in over 40% of the pathogen-antibiotic combinations, with an annual average increase of 5-15%. Dr Tedros Adhanom Ghebreyesus, WHO Director General, says antimicrobial resistance (AMR) outpaces modern medical advances. The Global antibiotic resistance surveillance report 2025 covers eight common bacterial pathogens that are rising i

MEASLES POINT-OF-CARE DIAGNOSTICS

DNAiTECH is contributing to a new project, “Development of a Molecular Rapid Detection Test for Measles Virus Diagnosis” supported by...

S-TECH OPERATIONAL VIDEO: PROCESSING SERUM SAMPLES FOR EV ISOLATION

Attached is our latest video demonstrating the versatility of S-TECH for the isolation of subcellular particles from human serum. Our EV...

S-TECH OPERATIONAL VIDEO: ISOLATION AND TRPS ANALYSIS OF URINARY SUBCELLULAR PARTICLES

Subcellular particle isolation, purification, concentration and buffer exchange is easy using our S-TECH technology with its highly...

VESICLE ISOLATION USING DNAiTECH'S S-TECH SYSTEM WITH TRACK-ETCHED MEMBRANES

S-TECH is DNAiTECH’s sample processing technology. We have now added track-etched membranes to S-TECH and these membranes enable high...

PLACID TECHNOLOGY COMBINED WITH S-TECH NUCLEIC ACID EXTRACTION

According to the World Health Organization, an ideal POC diagnostic must be Affordable, Sensitive, Specific, User-friendly, Rapid/Robust,...

PLACID: paper-based LAMP-CRISPR Integrated diagnostics

DNAiTECH is pioneering the development of PLACID, a new approach for point-of-care molecular testing that will bring disease detection...

Need more details? Contact us

We are here to assist. Contact us by phone, email or via our social media channels.